Characteristics of recipients whose kidney allograft has functioned for more than 20 years

Experimental and Clinical Transplantation

Volumn 6, Issue 2, 2008, Pages 155-160

  El Agroudy, Amgad E ^a   El Dahshan, Khaled ^a   Abbass, Tarek M ^a   Ismail, Amani M ^a   Shokeir, Ahmed A ^a   Ghoneim, Mohamed A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Long term; Renal allograft; Survival

Indexed keywords

AZATHIOPRINE; BLEOMYCIN; CYCLOSPORIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METHYLPREDNISOLONE; OKT 3; ORAL ANTIDIABETIC AGENT; PREDNISOLONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; FOLLOW UP; GLOMERULOSCLEROSIS; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREDICTION; PROGNOSIS;

ADOLESCENT; ADULT; BIOPSY; CHILD; CREATININE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; HYPERTENSION; INCIDENCE; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 53649091872     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Flechner SM, Novick AC, Braun WE, Popowniak KL, Steinmuller D. Functional capacity and rehabilitation of recipients with a functioning renal allograft for ten years or more. Transplantation. 1983;35(6):572-576.
2. Terasaki PI, McClelland ID, Yuge J, et al. Advances in kidney transplantation 1985-1995. In: Cecka JM, Terasaki PI, eds. Clinical Transplants Los Angeles, CA: UCLA Tissue Typing Laboratory; 1996:487-501.
3. Tanaka T, Takahara S, Hatori M, et al. The differences between late graft loss group and long-term graft survival group in renal transplantation. Clin Transplant. 2001;15(suppl 5):16-21.
4. El-Agroudy AE, Bakr MA, Hassan NA, et al. Characteristics of long-term live-donor renal allograft survivors. Am J Nephrol. 2003;23(3):165-171.
5. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant. 2004;4(8):1289-1295.
6. Tojimbara T, Fuchinoue S, Iwadoh K, et al. Improved outcomes of renal transplantation from cardiac death donors: a 30-year single center experience. Am J Transplant. 2007;7(3):609-617.
7. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342(9):605-612.
8. Kyllönen L, Koskimies S, Salmela K. Renal transplant recipients with graft survival longer than 20 years: report on 107 cases. Transplant Proc. 2001 Jun;33(4):2444-2445.
9. Gueco IP, Evans BD, Calne RY. Prolonged survival after renal transplantation. A study of 54 patients who lived ten or more years after operation with functioning allografts. Transplant Proc. 1985;17(1):108-109.
10. Silkensen JR. Long-term complications in renal transplantation. J Am Soc Nephrol. 2000;11(3):582-588.
11. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int. 1998 Jan;53(1):217-222.
12. Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA. 2000;283(5):633-638.
13. Braun WE, Popowniak KL, Nakamoto S, Gifford RW Jr, Straffon RA. The fate of renal allografts functioning for a minimum of 20 years (level 5A)-indefinite success or beginning of the end? A proposed classification of long-term allograft survivals. Transplantation. 1995;60(8):784-790.
14. Prommool S, Jhangri GS, Cockfield SM, Halloran PF. Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol. 2000;11(3):565-573.
15. Ashraf S, Parrott NR, Dyer P, Roberts I, Johnson RW. Clinical response and temporal patterns of acute cellular rejection: relationship to chronic transplant nephropathy. Transpl Int. 1998;11(suppl 1):S5-S9.
16. Varghese Z. Immunologic and nonimmunologic correlates of chronic renal allograft dysfunction. Transplant Proc. 1999;31(8):3356-3338.
17. Joseph JT, Kingsmore DB, Junor BJ, et al. The impact of late acute rejection after cadaveric kidney transplantation. Clin Transplant. 2001;15(4):221-227.
18. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation. 1995;59(7):962-968.
19. Kouli F, Morrell CH, Ratner LE, Kraus ES. Impact of donor/recipient traits independent of rejection on long-term renal function. Am J Kidney Dis. 2001;37(2):356-365.
20. Opelz G. HLA compatibility and kidney grafts from unrelated live donors. Collaborative Transplant Study. Transplant Proc. 1998;30(3):704-705.
21. OkamotoM, Nobori S, Higuchi A, et al. Clinicopathological evaluation of renal allografts of four patients by 20-year protocol biopsies. Clin Transplant. 2003;17(suppl 10):20-24.
22. Halloran PF. Immunosuppression in the postadaptation period. Transplantation. 2000;70(1):3-5.